The expansion will allow more Medicare patients access to Next Generation Sequencing to reduce mortality and improve health outcomes for inherited cancers. Genetic testing can help patients and their providers better understand what treatments or clinical trials would work best for their cancer cells.
Medicare first started covering laboratory tests using NGS in March 2018 for specific patients with advanced cancer.
More articles on healthcare finance:
Bon Secours to close Kentucky hospital, affecting 1,000 employees
Trump ‘going to look’ at Medicare cuts
Los Angeles hospital closes after purchase deal falls through
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.